 AGOURA HILLS, California, Feb. 22, 2021 GLOBE NEWSWIRE -- Mateon Therapeutics, Inc. OTCQB:MATN Mateon, a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health and Windlas Biotech Pvt. Ltd. Windlas, a leading Indian pharmaceutical contract drug development and manufacturing organization, announced today the launch in India of PulmoHealTM a first-of-its-kind integrated, consumer-centric solution for respiratory wellness. 